Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Ifinatamab deruxtecan |
Trade Name | |
Synonyms | DS7300a|DS 7300a|DS7300|DS 7300|DS-7300|DS-7300a|I-DXd |
Drug Descriptions |
Ifinatamab deruxtecan (DS-7300a) is a monoclonal antibody targeting B7-H3 (CD276) conjugated to a DNA topoisomerase I inhibitor which may lead to antitumor activities (Ann Oncol (2023) 34 (suppl_2):S481-S482). |
DrugClasses | CD276 Antibody 16 |
CAS Registry Number | 2484870-92-8 |
NCIT ID | C171577 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Carboplatin + Ifinatamab deruxtecan | Atezolizumab Carboplatin Ifinatamab deruxtecan | 0 | 1 |
Atezolizumab + Ifinatamab deruxtecan | Atezolizumab Ifinatamab deruxtecan | 0 | 1 |
Decitabine + Ifinatamab deruxtecan | Decitabine Ifinatamab deruxtecan | 0 | 0 |
Ifinatamab deruxtecan | Ifinatamab deruxtecan | 0 | 4 |